Equity Overview
Price & Market Data
Price: $0.0849
Daily Change: +$0.0₃4 / 0.47%
Daily Range: $0.08 - $0.089
Market Cap: $14,601,183
Daily Volume: 52,640
Performance Metrics
1 Week: -5.67%
1 Month: -8.16%
3 Months: 40.10%
6 Months: 11.42%
1 Year: 34.87%
YTD: -12.11%
Details
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.